Please use this identifier to cite or link to this item: https://idr.l3.nitk.ac.in/jspui/handle/123456789/12387
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRamprasad, J.-
dc.contributor.authorNayak, N.-
dc.contributor.authorUdayakumar, D.-
dc.contributor.authorYogeeswari, P.-
dc.contributor.authorSriram, D.-
dc.date.accessioned2020-03-31T08:39:08Z-
dc.date.available2020-03-31T08:39:08Z-
dc.date.issued2015-
dc.identifier.citationBioorganic and Medicinal Chemistry Letters, 2015, Vol.25, 19, pp.4169-4173en_US
dc.identifier.urihttps://idr.nitk.ac.in/jspui/handle/123456789/12387-
dc.description.abstractA new series of triazole-imidazo[2,1-b][1,3,4]thiadiazole hybrids (6a-s, 7a) were designed by a molecular hybridisation approach and the target molecules were synthesized via one pot click chemistry protocol. All the intermediates and final molecules were characterised using spectral methods and one of the target compounds (6c) was analysed by the single crystal XRD study. The derivatives were screened for their antimycobacterial activity against Mycobacterium tuberculosis H37Rv strain. Two compounds, 6f and 6n, demonstrated significant growth inhibitory activity against the bacterial strain with a MIC of 3.125 ?g/mL. The presence of chloro substituent on the imidazo[2,1-b][1,3,4]thiadiazole ring and ethyl, benzyl or cyanomethylene groups on the 1,2,3-triazole ring enhance the inhibition activity of the molecules. The active compounds are not toxic to a normal cell line which signifies the lack of general cellular toxicity of these compounds. 2015 Elsevier Ltd. All rights reserved.en_US
dc.titleOne-pot synthesis of new triazole - Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activityen_US
dc.typeArticleen_US
Appears in Collections:1. Journal Articles

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.